Bitcoin traders have witnessed some impressive gains over the last few last weeks, but recent sessions have displayed a stalling, bearish tone. Amongst the cryptocurrencies, Binance has been the standout performer in recent sessions. Parts of the downside reversal in Bitcoin can be attributed to SEC news with regard to pending Bitcoin ETF applications. But … Read more
Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) has been the center of attention for several savvy investors as of late, and for good reason. The company has released several positive bits of news over the past few weeks, leading to the stock nearly doubling in value since April 10th. So, what’s the big deal? Why do investors … Read more
Jaguar Health Inc (NASDAQ: JAGX) has come up on our radar quite a bit over the last few trading sessions. With a veterinary treatment coming close to approval, the stock has been flying. However, is this really a strong opportunity, or are we seeing overreactions to news, leading to gains that will soon fizzle? Today, we’ll … Read more
22nd Century Group Inc (NYSEAMERICAN: XXII) has been an incredibly interesting stock to watch over the past year. In fact, over the past year, the stock has nearly tripled in value, making it one of the best performing on the market in this period. However, is the growth going to fizzle or is XXII a great … Read more
MannKind Corporation (NASDAQ: MNKD) has been a very interesting stock to watch since 2014, when the United States Food and Drug Administration (FDA) approved the company’s inhaled insulin known as Afrezza. Considering that there were no needles to be used and the insulin was a fast-acting, after-meals option, investors believed that the treatment would fly off … Read more
Idera Pharmaceuticals (NASDAQ: IDRA) is a very interesting stock to watch. As far as price action goes, the value of the stock has seen some pretty dramatic rises and falls over the past year. However, the actual movement at the end here is pretty minimum. Today, the stock trades at $1.97 per share. That’s only a … Read more
Northern Dynasty Minerals Ltd (NYSEAMERICAN: NAK) has been on a long and bumpy road. In fact, while the company has released several positive press releases surrounding its flagship project, the Pebble Project, we’ve seen some pretty heavy declines since the year clicked over to 2018. Nonetheless, while many seem to be abandoning ship, there are plenty … Read more
When we think of Helios and Matheson Analytics (HMNY), the first thing that comes to mind is MoviePass, and for good reason. Back in August of last year, the company acquired a majority stake in MoviePass. While Helios and Matheson did have the RedZone Maps product before it acquired MoviePass, there’s no denying the fact … Read more
Exact Sciences (EXAS), the company behind the colorectal screening product, Cologuard, has been an interesting company to watch as of late. The stock recently caught my attention when I realized just how much Cologuard was being used. We’ll get into that in a big. For those of you who haven’t been following the company, Exact … Read more
Novavax (NVAX) is a company that has recently grabbed my attention. With strong gains over the past month and speculated buyout possibilities, I had to take a dive and see what I was missing. For those of you who are new to Novavax, the company is a specialty biotechnology company focused on the development of … Read more